Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 30:12:1535401.
doi: 10.3389/fcvm.2025.1535401. eCollection 2025.

The structure and function of mitofusin 2 and its role in cardiovascular disease through mediating mitochondria-associated endoplasmic reticulum membranes

Affiliations
Review

The structure and function of mitofusin 2 and its role in cardiovascular disease through mediating mitochondria-associated endoplasmic reticulum membranes

Yuhu Lv et al. Front Cardiovasc Med. .

Abstract

Cardiovascular disease (CVD) remains a leading cause of death globally, posing a major public health challenge. Due to the complexity of CVD's etiology, understanding its pathogenesis has been a significant challenge and research focus. In recent years, the communication between organelles has gained increasing attention, with mitochondria-associated endoplasmic reticulum (ER) membranes (MAMs) emerging as a key structural component that facilitates dialogue between the mitochondria and the ER. Numerous studies have highlighted that proteins located in MAMs may play a role in the development of CVD. Among these, mitofusin 2 (MFN2), a protein found on the outer mitochondrial and ER membranes, has garnered particular interest due to its widespread presence in MAMs. This review aims to sort out current research on MFN2, focusing on its potential involvement in myocardial protection through its mediation of MAMs. We discuss how MFN2-mediated MAMs may contribute to the protection against various CVDs, including myocardial ischemia/reperfusion injury, diabetic cardiomyopathy, dilated cardiomyopathy, pathological myocardial hypertrophy, cardiotoxicity, and heart failure. However, given the functional diversity of MFN2, the current body of research remains controversial, and further studies are urgently needed to clarify its precise mechanisms of action.

Keywords: cardioprotection; cardiovascular disease; endoplasmic reticulum; mitochondria; mitochondria-associated endoplasmic reticulum membranes; mitofusin 2.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of the structure of mitofusin 2 and its involvement in mitochondrial fusion. (A) Classical MFN2 structural model. (B) Latest predicted MFN2 structural model. (C) MFN2-mediated mitochondrial fusion process. MFN2/1, mitofusin 2/1; IMM, inner mitochondrial membrane; OMM, outer mitochondrial membrane; IMS, mitochondrial intermembrane space; and OPA1, optic atrophy factor 1.
Figure 2
Figure 2
Functional schematic of MFN2. MFN2, mitofusin 2.
Figure 3
Figure 3
The role of MFN2-mediated MAMs in cardiovascular disease. MFN2, mitofusin 2; MAMs, mitochondria-associated endoplasmic reticulum (ER) membranes.

Similar articles

References

    1. Dhaun N, Webb DJ. Endothelins in cardiovascular biology and therapeutics. Nat Rev Cardiol. (2019) 16:491–502. 10.1038/s41569-019-0176-3 - DOI - PubMed
    1. Lv Y, Yu Z, Zhang P, Zhang X, Li H, Liang T, et al. The structure and function of FUN14 domain-containing protein 1 and its contribution to cardioprotection by mediating mitophagy. Front Pharmacol. (2024) 15:1389953. 10.3389/fphar.2024.1389953 - DOI - PMC - PubMed
    1. Lv YH, Cheng L, Peng FL. Compositions and functions of mitochondria-associated endoplasmic Reticulum membranes and their contribution to cardioprotection by exercise preconditioning. Front Physiol. (2022) 13:910452. 10.3389/fphys.2022.910452 - DOI - PMC - PubMed
    1. Lu B, Chen X, Ma Y, Gui M, Yao L, Li J, et al. So close, yet so far away: the relationship between MAM and cardiac disease. Front Cardiovasc Med. (2024) 11:1353533. 10.3389/fcvm.2024.1353533 - DOI - PMC - PubMed
    1. Liu Y, Huo J-L, Ren K, Pan S, Liu H, Zheng Y, et al. Mitochondria-associated endoplasmic reticulum membrane (MAM): a dark horse for diabetic cardiomyopathy treatment. Cell Death Discov. (2024) 10:148. 10.1038/s41420-024-01918-3 - DOI - PMC - PubMed

LinkOut - more resources